Bicarbonate

Bicarbonate

SCHEMBL3395196

O=C(O)O.O=C([O-])O.O=C([O-])O.[H+].[Na+]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA4 P22748 6/20 0.50
CA1 P00915 3/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 1/20 0.50
FAHD1 Q6P587 1/20 0.50
MEN1 O00255 1/20 0.40
LDHA P00338 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 2/20 0.38
CASP1 P29466 1/20 0.38
FFAR3 O14843 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL8962302 0.95 CA1 (0.56) CA4CA1CA2CA9FAHD1
Bicarbonate SCHEMBL16568879 0.95 CA1 (0.56) CA4CA1CA2CA9FAHD1
Bicarbonate SCHEMBL9247593 0.95 CA1 (0.56) CA4CA1CA2CA9FAHD1
Bicarbonate SCHEMBL10903415 0.95 CA1 (0.56) CA4CA1CA2CA9FAHD1
Bicarbonate SCHEMBL3815650 0.95 CA1 (0.56) CA4CA1CA2CA9FAHD1
Bicarbonate SCHEMBL10901890 0.95 CA1 (0.56) CA4CA1CA2CA9FAHD1
Bicarbonate SCHEMBL8862333 0.95 CA1 (0.56) CA4CA1CA2CA9FAHD1
Bicarbonate SCHEMBL456119 0.95
Bicarbonate SCHEMBL8468228 0.95 CA1 (0.56) CA4CA1CA2CA9FAHD1
Bicarbonate SCHEMBL15428445 0.95 CA1 (0.56) CA4CA1CA2CA9FAHD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8889184-B2 Particulate form of a pharmaceutical composition which is easy to swallow LOSAN PHARMA GMBH (DE) 2014-11-18 US disclosed
EP-2051693-B1 PHARMACEUTICAL COMPOSITIONS EASY TO SWALLOW, NOT CAUSING ANY UNPLEASANT ORAL SENSATION AND COMPRISING PARTICLES WITH AN ACTIVE PRINCIPLE LOSAN PHARMA GMBH (DE) 2010-10-13 EP disclosed
EP-2051693-A1 PHARMACEUTICAL COMPOSITIONS EASY TO SWALLOW, NOT CAUSING ANY UNPLEASANT ORAL SENSATION AND COMPRISING PARTICLES WITH AN ACTIVE PRINCIPLE Losan Pharma GmbH (DE) 2009-04-29 EP disclosed
US-20080063713-A1 Outermost coating layer contains neutral methacrylic acid esters copolymer capable of forming a gel with water; sodium glycin carbonate releasing carbon dioxide; adjuvants; promoting salivation with sucrose, glucose, maltodextrin, sorbitol, mannitol, xylitol, maltitol; easily ingestible without water LOSAN PHARMA GMBH (DE) 2008-03-13 US disclosed
WO-2008019854-A1 PHARMACEUTICAL COMPOSITIONS EASY TO SWALLOW, NOT CAUSING ANY UNPLEASANT ORAL SENSATION AND COMPRISING PARTICLES WITH AN ACTIVE PRINCIPLE LOSAN PHARMA GMBH (DE) 2008-02-21 WO disclosed